ABL1 and melanoma: During melanoma progression, ABL1/2 drive proliferation, survival, invasion, and metastasis by phosphorylating substrates including the CRK/CRKL adapter proteins, which results in induction of transcription factors and proteases that degrade the extracellular matrix [6,8].